By Fatma Younis
Democrats' midterm election victories have given them significant leverage to reshape U.S. healthcare policy, from restoring expired Affordable Care Act subsidies to reversing Medicaid cuts and probing the Trump administration's health decisions. However, any legislation still requires President Donald Trump's signature, setting up potential clashes over the next two years.
ACA subsidies
House Minority Leader Hakeem Jeffries has identified restoring the enhanced ACA tax credits as a primary objective. Those subsidies expired at the end of 2025, causing monthly premiums to double or triple for millions and prompting about 3 million people to drop coverage. Premiums are rising by double digits for a second consecutive year, driving some major insurers to exit the market. Larry Levitt of KFF said a negotiated deal with Trump could backdate relief to January 2027, refunding higher premiums paid. Former Obama adviser Ezekiel Emanuel cautioned Democrats against overreaching and neglecting employer-sponsored insurance costs.
Medicaid cuts
Democrats are expected to push back against Medicaid work requirements enacted under Trump's "big, beautiful bill," which could strip coverage from millions due to paperwork burdens. A federal judge in Boston recently blocked a rule forcing medically frail patients to prove impairment and granted states six additional months for implementation. Levitt predicted Trump would veto any rollback legislation. Meanwhile, Georgia, Texas, and Wisconsin elected Democratic governors, potentially reviving Medicaid expansion in those states, though Yaver noted the loss of federal financial incentives complicates the outlook.
Affordability and corporate greed
Democrats may find common ground with Trump on lowering prescription drug prices, building on his TrumpRx discount website and "most favored nation" pricing deals. Emanuel sees potential for a broad agreement, but former Biden adviser John Barkett questioned the impact of Trump's opaque manufacturer deals. Bipartisan support is growing for limiting prior authorization requirements that delay care, and both parties are targeting rising hospital costs and pharmacy benefit manager practices that inflate drug prices.
Investigations into the administration
With control of congressional committees, Democrats plan hearings and subpoenas targeting Health Secretary Robert F. Kennedy Jr. over changes to the CDC vaccine advisory panel, the federal vaccine schedule, and the Vaccine Injury Compensation Program. Measles cases have surpassed 4,850 this year, the highest in at least three decades. Barkett said investigations could distract the administration and generate campaign material for 2028.
'Medicare for All'
"Medicare for All" remains a central goal for many Democrats despite its slim chances under a Republican president. Emanuel argued the proposal is currently the only comprehensive plan available and urged development of alternatives before 2028. Yaver described the push as largely symbolic, given Trump's promised veto of major progressive legislation.
